Since the development of gene editing technology, precise targeted integration has always been the "holy grail" pursued by researchers. Recently, the team of Noritaka Adachi from Yokohama City University published an important discovery in PNAS: "Homology- arm length of donor DNA affects the impact of Msh2 loss on homologous recombination-mediated gene targeting". This study revealed a key factor affecting gene targeting efficiency - the subtle relationship between the length of the homology arm of donor DNA and the mismatch repair protein Msh2.
The research team discovered an interesting phenomenon during the gene targeting experiment: when using donor DNA with the same gene sequence for targeted integration, the presence or absence of Msh2 protein will produce completely different effects, and this difference actually depends on the length of the homology arm.
Specifically, when the researchers compared two targeting vectors of different lengths:
To further confirm this finding, the research team constructed multiple targeting vectors of different lengths for systematic analysis. The results revealed an important rule: When a single homology arm is as short as 1.7kb or shorter, the inhibitory effect of Msh2 will be apparent. This finding breaks the previous belief that "homologous DNA is not affected by mismatch repair".
More importantly, the data revealed a clear negative correlation between the total homology arm length and the degree of Msh2 influence - the shorter the homology arm, the more obvious the efficiency improvement brought by Msh2 deficiency.
The study further found that gene targeting can be achieved through two different mechanisms.
This finding explains why the effect of Msh2 becomes independent of homology arm length in HR-deficient cells.
When Msh2, LIG4 and POLQ were inhibited simultaneously, the targeting efficiency of the short homology arm vector was increased by 20 times! This discovery is of great significance to gene editing applications.
The study proposed an innovative combination strategy: Msh2 inhibition + NHEJ inhibition + short homology arm vector, which can significantly improve the efficiency of targeted integration. This is of special value for gene editing systems that are limited by vector length (such as rAAV vectors, the total length cannot exceed 4kb).
The research team proposed an explanatory model. During homologous recombination, when DNA double-strand breaks undergo end resection, short homologous arms may not provide sufficiently long homologous sequences to overcome the interference of Msh2 on non-homologous sequences (such as marker genes). This is highly consistent with the known average length of DNA end resection (about 1-2kb).
Figure 1. Model for Msh2-mediated suppression of TI with a short-arm targeting vector. (Saito, et al., 2025)
This study not only reveals a new mechanism of gene targeting, but also provides a practical strategy to improve gene editing efficiency. In particular, for gene therapy applications that require the use of short vectors, this discovery may bring revolutionary improvements.
In the future, combined with modern gene editing tools such as CRISPR/Cas9, through a combination of reasonable cell line selection, vector design and protein inhibition strategies, we are expected to achieve more efficient and precise gene editing, opening up new possibilities for gene therapy and biomedical research.
Cat# | Product Name | Size |
ACC-100 | GV3101 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-103 | EHA105 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-105 | AGL1 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-107 | LBA4404 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-108 | EHA101 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-117 | Ar.Qual Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-118 | MSU440 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-119 | C58C1 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-121 | K599 Chemically Competent Cell | 10 tubes (100μL/tube) 20 tubes (100μL/tube) 50 tubes (100μL/tube) 100 tubes (100μL/tube) |
ACC-122 | Ar.A4 Electroporation Competent Cell | 10 tubes (50μL/tube) 20 tubes (50μL/tube) 50 tubes (50μL/tube) |